Dow Up 0.97% Nasdaq Up 1.69%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.63 Down 0.02(0.55%) 12:38PM EDT - Nasdaq Real Time Price
Prev Close:3.65
Open:3.70
Bid:3.63 x 1300
Ask:3.64 x 1100
1y Target Est:6.33
Beta:0.25
Next Earnings Date:N/A
Day's Range:3.60 - 3.72
52wk Range:3.04 - 6.17
Volume:131,207
Avg Vol (3m):602,251
Market Cap:338.00M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUDown 0.55%338.00M
BIIBUp 2.61%75.46B
GSKUp 0.23%104.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):37.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.46
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback